Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19405430 | 0.80 | — | — | |
| SCHEMBL18242458 | 0.80 | — | — | |
| SCHEMBL9257902 | 0.80 | — | — | |
| SCHEMBL454837 | 0.80 | — | — | |
| SCHEMBL9201515 | 0.80 | — | — | |
| SCHEMBL8556914 | 0.80 | — | — | |
| SCHEMBL19405667 | 0.80 | — | — | |
| SCHEMBL5402633 | 0.80 | — | — | |
| SCHEMBL10631014 | 0.80 | — | — | |
| SCHEMBL8308460 | 0.77 | TSHR (0.42) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1038 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114105993-B | Synthesis method of chiral pyrroloimidazole compound | 大连理工大学 | 2023-03-10 | — | — | CN | claimed |
| CN-114105993-A | Synthesis method of chiral pyrroloimidazole compound | 大连理工大学 | 2022-03-01 | — | — | CN | claimed |
| CN-109942553-B | Synthesis and conversion method of chiral 3,4, 6-trisubstituted tetrahydro 2H-pyran-2-one compound | 大连理工大学 | 2020-09-29 | — | — | CN | claimed |
| CN-109942553-A | A kind of synthesis of tri- substituted-tetrahydro 2H- pyran-2-one compound of chirality 3,4,6- and its method for transformation | 大连理工大学 | 2019-06-28 | — | — | CN | claimed |
| EP-3197507-A1 | MALODOR REDUCTION COMPOSITIONS | The Procter and Gamble Company (US) | 2017-08-02 | — | — | EP | claimed |
| WO-2016049389-A1 | MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| EP-1653960-A4 | MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST | AMGEN INC (US) | 2008-11-26 | — | — | EP | claimed |
| EP-1653960-A2 | MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST | AMGEN INC. (US) | 2006-05-10 | — | — | EP | claimed |
| US-20050215526-A1 | Melanin concentrating hormone receptor antagonist | AMGEN, INC. | 2005-09-29 | — | — | US | claimed |
| WO-2005019167-A2 | MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST | AMGEN, INC. (US) | 2005-03-03 | — | — | WO | claimed |
| CN-1440390-A | Substituted diamine derivatives as motilin antagonists | ORTHO MCNEIL PHARM INC (US) | 2003-09-03 | — | — | CN | claimed |
| US-6509426-B2 | Dichloro(1,1'-dimethylsilylenebis(2-methyl-4-(4-methoxyphenyl) -4H-azulenyl))zirconium, for example; can produce polyolefin with high molecular weight and high melting point for extrusion or injection moldability | JAPAN POLYCHEM CORPORATION (JP) | 2003-01-21 | — | — | US | claimed |
| US-20010041794-A1 | Nucleotide analogs | GILEAD SCIENCES, INC. | 2001-11-15 | — | — | US | claimed |
| US-5798340-A | ANTITUMOR/ANTINEOPLASTIC ACTIITY, VIRICIDES; BROAD SPECTRUM MICROBIOCIDES; THIOPHOSPHONATES HYDROLYZABLE IN VIVO; ORAL ADMINISTRATION; BIOAVAILABILITY; NONTOXIC; POTENCY | GILEAD SCIENCES, INC. (US) | 1998-08-25 | — | — | US | claimed |
| EP-0641786-B1 | Process for producing optically active alcohol | SUMITOMO CHEMICAL CO (JP) | 1997-08-20 | — | — | EP | claimed |
| EP-0641786-A1 | Process for producing optically active alcohol | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-03-08 | — | — | EP | claimed |
| US-5144039-A | Reducing prochiral ketone with metal borohydride modified with optically active amino alcohol in presence of ether or sulfide | SUMITOMO ELECTRIC COMPANY, LIMITED (JP) | 1992-09-01 | — | — | US | claimed |
| EP-0381434-A1 | Process for producing optically active alcohol | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-08-08 | — | — | EP | claimed |
| EP-0062773-B1 | 4-Phenyl-1,2,3-thiadiazoles as herbicide extenders | STAUFFER CHEMICAL COMPANY (US) | 1984-12-05 | — | — | EP | claimed |
| EP-0062773-A1 | 4-Phenyl-1,2,3-thiadiazoles as herbicide extenders | STAUFFER CHEMICAL COMPANY (US) | 1982-10-20 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010041794-A1 | Nucleotide analogs | PNP, NUDT1, TYMP | TSHR 2855/4885LMNA 1209/4885 |
| US-20050215526-A1 | Melanin concentrating hormone receptor antagonist | MCHR1, MC1R, NPY1R | TSHR 17/4885LMNA 2996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.